HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janice Tsui Selected Research

Vascular Malformations

10/2022Incidence of major complications from embolo-sclerotherapy of head and neck vascular malformations in a single specialist centre.
1/2022Quality of life and mental health of patients with vascular malformations in a single specialist center in the United Kingdom.
7/2021Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations.
2/2021Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
1/2021Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations.
1/2020Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janice Tsui Research Topics

Disease

6Vascular Malformations
10/2022 - 01/2020
3Hypoxia (Hypoxemia)
01/2020 - 09/2009
3Inflammation (Inflammations)
01/2020 - 01/2012
3Ischemia
07/2014 - 07/2005
2Pain (Aches)
01/2022 - 07/2021
2Infections
10/2021 - 03/2019
2Wounds and Injuries (Trauma)
01/2020 - 07/2012
2Chronic Limb-Threatening Ischemia
07/2014 - 02/2011
1Cellulitis
10/2022
1Necrosis
10/2022
1Fibrosis (Cirrhosis)
10/2022
1Abdominal Aortic Aneurysm
09/2022
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2022
1Arteriovenous Malformations (Arteriovenous Malformation)
01/2022
1Drug-Related Side Effects and Adverse Reactions
12/2021
1Pericarditis
12/2021
1COVID-19
10/2021
1Virus Diseases (Viral Diseases)
10/2021
1T-Cell Leukemia (Leukemia, T Cell)
03/2021
1Leukemia
03/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2021
1Contracture
02/2021
1Neoplasms (Cancer)
11/2019
1Wound Infection (Wound Infections)
05/2019
1Sepsis (Septicemia)
03/2019
1Vascular Remodeling
01/2019
1Hyperplasia
12/2016
1Chronic Kidney Failure (Chronic Renal Failure)
12/2016
1Fistula
12/2016
1Ulcer
07/2012
1Diabetic Foot
07/2012
1Thromboembolism
01/2012
1Peripheral Arterial Disease
01/2012
1Cardiovascular Diseases (Cardiovascular Disease)
01/2012
1Atherosclerosis
01/2012
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2012
1Reperfusion Injury
01/2012
1Systemic Scleroderma (Systemic Sclerosis)
06/2011
1Autoimmune Diseases (Autoimmune Disease)
06/2011

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2021 - 07/2012
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2022 - 07/2021
2ErythropoietinFDA Link
01/2012 - 08/2010
1Crystalloid SolutionsIBA
01/2022
1ColchicineFDA LinkGeneric
12/2021
1C-Reactive ProteinIBA
12/2021
1Sirolimus (Rapamycin)FDA Link
07/2021
1ProteomeIBA
03/2021
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1Toll-Like Receptor 4IBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1vacuolar processing enzymeIBA
11/2019
1Peptide Hydrolases (Proteases)FDA Link
11/2019
1polihexanideIBA
05/2019
1Polyurethanes (Polyurethane)IBA
05/2019
1Carbapenems (Carbapenem Antibiotics)IBA
03/2019
1Polymyxins (Polymyxin)IBA
03/2019
1C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
01/2019
1ChemokinesIBA
12/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2014
1LigandsIBA
07/2014
1Interleukin-6 (Interleukin 6)IBA
07/2014
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
07/2014
1Caspase 3 (Caspase-3)IBA
07/2014
1Connexin 43 (Connexin43)IBA
07/2012
1ConnexinsIBA
07/2012
1Cadherins (E-Cadherin)IBA
07/2012
1Pattern Recognition ReceptorsIBA
01/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2012
1Toll-Like Receptor AgonistsIBA
01/2012
1Conditioned Culture MediaIBA
06/2011
1Thrombospondin 1IBA
06/2011
1CollagenIBA
06/2011
1chetominIBA
09/2009
1Transcription Factors (Transcription Factor)IBA
09/2009
1salicylhydroxamic acid (SHAM)IBA
07/2005
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
07/2005
1Arginine (L-Arginine)FDA Link
07/2005

Therapy/Procedure

5Therapeutics
12/2021 - 03/2019
3Sclerotherapy
10/2022 - 01/2021
2Tracheostomy
10/2022 - 10/2021
2Catheters
10/2022 - 02/2021
2Surgical Amputation (Amputations)
07/2014 - 07/2012
1Debridement
10/2022
1Imaging Phantoms
09/2022
1Resuscitation
01/2022
1Immunotherapy
12/2021
1Drug Therapy (Chemotherapy)
12/2021
1Tenotomy
02/2021
1Ligation
01/2020
1Renal Dialysis (Hemodialysis)
12/2016
1Endarterectomy (Thromboendarterectomy)
02/2011
1Laparotomy
07/2005